They produced a weight loss drug that made them the most valuable company in Europe. "We will introduce another obesity drug, it will be the first such combination in history"

forbes.pl

Factuality

Ownership

They produced a weight loss drug that made them the most valuable company in Europe. "We will introduce another obesity drug, it will be the first such combination in history"

There are over a billion people worldwide living with chronic diseases such as diabetes and obesity, and we still help treat only a fraction of them, i.e. approximately 42 million. There is still a lot to do – says Camilla Sylvest, vice president of Danish Novo Nordisk, the producer of Ozempik and Wegovy, in her first interview for Polish media.